393 related articles for article (PubMed ID: 17501762)
1. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
3. Failure to diagnose recent hepatitis C virus infections in London injecting drug users.
Aarons E; Grant P; Soldan K; Luton P; Tang J; Tedder R
J Med Virol; 2004 Aug; 73(4):548-53. PubMed ID: 15221898
[TBL] [Abstract][Full Text] [Related]
4. Clearance of hepatitis C virus after newly acquired infection in injection drug users.
Jauncey M; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson W; Kaldor JM; van Beek I; Dore GJ
J Infect Dis; 2004 Oct; 190(7):1270-4. PubMed ID: 15346337
[TBL] [Abstract][Full Text] [Related]
5. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
[TBL] [Abstract][Full Text] [Related]
6. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
[TBL] [Abstract][Full Text] [Related]
7. A method to detect the incidence of hepatitis C infection among injecting drug users in Glasgow 1993-98.
Roy KM; Goldberg D; Taylor A; Hutchinson S; MacDonald L; Wilson KS; Cameron SO
J Infect; 2001 Oct; 43(3):200-5. PubMed ID: 11798260
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
Hallinan R; Byrne A; Amin J; Dore GJ
J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
[TBL] [Abstract][Full Text] [Related]
9. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus.
Currie SL; Ryan JC; Tracy D; Wright TL; George S; McQuaid R; Kim M; Shen H; Monto A
Drug Alcohol Depend; 2008 Jan; 93(1-2):148-54. PubMed ID: 17977668
[TBL] [Abstract][Full Text] [Related]
10. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots.
Hope VD; Hickman M; Ngui SL; Jones S; Telfer M; Bizzarri M; Ncube F; Parry JV
J Viral Hepat; 2011 Apr; 18(4):262-70. PubMed ID: 20456636
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
Idrees M; Lal A; Naseem M; Khalid M
J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience.
Roy E; Boudreau JF; Boivin JF
Drug Alcohol Depend; 2009 Jun; 102(1-3):158-61. PubMed ID: 19251382
[TBL] [Abstract][Full Text] [Related]
15. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
Aitken CK; Lewis J; Tracy SL; Spelman T; Bowden DS; Bharadwaj M; Drummer H; Hellard M
Hepatology; 2008 Dec; 48(6):1746-52. PubMed ID: 18844233
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.
Cavlek TV; Margan IG; Lepej SZ; Kolaric B; Vince A
J Med Virol; 2009 Aug; 81(8):1348-53. PubMed ID: 19551819
[TBL] [Abstract][Full Text] [Related]
18. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
19. Change in hepatitis C virus genotype in injecting drug users.
Aitken C; McCaw R; Jardine D; Bowden S; Higgs P; Nguyen O; Crofts N; Hellard M
J Med Virol; 2004 Dec; 74(4):543-5. PubMed ID: 15484265
[TBL] [Abstract][Full Text] [Related]
20. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users.
Roy E; Alary M; Morissette C; Leclerc P; Boudreau JF; Parent R; Rochefort J; Claessens C;
Int J STD AIDS; 2007 Jan; 18(1):23-7. PubMed ID: 17326858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]